nodes	percent_of_prediction	percent_of_DWPC	metapath
Nifedipine—ABCC3—Etoposide—uterine cancer	0.0531	0.0823	CbGbCtD
Nifedipine—CYP2A6—Progesterone—uterine cancer	0.0527	0.0816	CbGbCtD
Nifedipine—CYP1A1—Progesterone—uterine cancer	0.045	0.0697	CbGbCtD
Nifedipine—CYP2C8—Medroxyprogesterone Acetate—uterine cancer	0.0392	0.0607	CbGbCtD
Nifedipine—ABCC3—Doxorubicin—uterine cancer	0.0362	0.0561	CbGbCtD
Nifedipine—CYP3A7—Progesterone—uterine cancer	0.036	0.0558	CbGbCtD
Nifedipine—CYP3A7-CYP3A51P—Progesterone—uterine cancer	0.036	0.0558	CbGbCtD
Nifedipine—ABCC2—Carboplatin—uterine cancer	0.0287	0.0445	CbGbCtD
Nifedipine—CYP2C9—Medroxyprogesterone Acetate—uterine cancer	0.0273	0.0424	CbGbCtD
Nifedipine—CYP3A5—Progesterone—uterine cancer	0.027	0.0418	CbGbCtD
Nifedipine—CYP2C8—Progesterone—uterine cancer	0.026	0.0402	CbGbCtD
Nifedipine—ABCC2—Etoposide—uterine cancer	0.0241	0.0374	CbGbCtD
Nifedipine—CYP1A2—Progesterone—uterine cancer	0.0201	0.0311	CbGbCtD
Nifedipine—CYP2C9—Progesterone—uterine cancer	0.0181	0.0281	CbGbCtD
Nifedipine—ABCB1—Progesterone—uterine cancer	0.0176	0.0272	CbGbCtD
Nifedipine—CYP2D6—Progesterone—uterine cancer	0.0166	0.0257	CbGbCtD
Nifedipine—ABCC2—Doxorubicin—uterine cancer	0.0165	0.0255	CbGbCtD
Nifedipine—CYP3A4—Medroxyprogesterone Acetate—uterine cancer	0.0159	0.0246	CbGbCtD
Nifedipine—CYP2E1—Etoposide—uterine cancer	0.0156	0.0241	CbGbCtD
Nifedipine—ABCB1—Dactinomycin—uterine cancer	0.0139	0.0216	CbGbCtD
Nifedipine—CYP3A5—Etoposide—uterine cancer	0.0121	0.0187	CbGbCtD
Nifedipine—CYP2C8—Etoposide—uterine cancer	0.0116	0.018	CbGbCtD
Nifedipine—CYP3A4—Progesterone—uterine cancer	0.0105	0.0163	CbGbCtD
Nifedipine—CYP2B6—Doxorubicin—uterine cancer	0.0105	0.0162	CbGbCtD
Nifedipine—CYP1A2—Etoposide—uterine cancer	0.00899	0.0139	CbGbCtD
Nifedipine—ABCB1—Etoposide—uterine cancer	0.00786	0.0122	CbGbCtD
Nifedipine—ABCB1—Doxorubicin—uterine cancer	0.00536	0.00831	CbGbCtD
Nifedipine—CYP2D6—Doxorubicin—uterine cancer	0.00505	0.00783	CbGbCtD
Nifedipine—CYP3A4—Etoposide—uterine cancer	0.00471	0.0073	CbGbCtD
Nifedipine—CALM2—semen—uterine cancer	0.00349	0.0483	CbGeAlD
Nifedipine—CALM1—semen—uterine cancer	0.00348	0.048	CbGeAlD
Nifedipine—CYP3A4—Doxorubicin—uterine cancer	0.00321	0.00498	CbGbCtD
Nifedipine—CALM2—oviduct—uterine cancer	0.00256	0.0354	CbGeAlD
Nifedipine—CALM2—artery—uterine cancer	0.0017	0.0234	CbGeAlD
Nifedipine—CALM1—artery—uterine cancer	0.00169	0.0233	CbGeAlD
Nifedipine—CACNA1H—myometrium—uterine cancer	0.00164	0.0226	CbGeAlD
Nifedipine—CALM2—exocrine gland—uterine cancer	0.00148	0.0204	CbGeAlD
Nifedipine—CALM1—exocrine gland—uterine cancer	0.00147	0.0203	CbGeAlD
Nifedipine—CACNA1C—myometrium—uterine cancer	0.00125	0.0172	CbGeAlD
Nifedipine—CACNA1H—smooth muscle tissue—uterine cancer	0.00124	0.0171	CbGeAlD
Nifedipine—CACNA1H—uterus—uterine cancer	0.00106	0.0147	CbGeAlD
Nifedipine—CACNA1D—uterine cervix—uterine cancer	0.00105	0.0145	CbGeAlD
Nifedipine—CALM3—myometrium—uterine cancer	0.00104	0.0144	CbGeAlD
Nifedipine—CACNA1H—female reproductive system—uterine cancer	0.000954	0.0132	CbGeAlD
Nifedipine—CACNA1C—smooth muscle tissue—uterine cancer	0.000943	0.013	CbGeAlD
Nifedipine—CACNA1C—decidua—uterine cancer	0.000924	0.0128	CbGeAlD
Nifedipine—CACNA1H—female gonad—uterine cancer	0.000868	0.012	CbGeAlD
Nifedipine—ABCC3—decidua—uterine cancer	0.000841	0.0116	CbGeAlD
Nifedipine—ABCC3—renal system—uterine cancer	0.000825	0.0114	CbGeAlD
Nifedipine—CALM2—myometrium—uterine cancer	0.00082	0.0113	CbGeAlD
Nifedipine—CALM1—myometrium—uterine cancer	0.000816	0.0113	CbGeAlD
Nifedipine—CACNB2—vagina—uterine cancer	0.000815	0.0113	CbGeAlD
Nifedipine—CALM3—uterine cervix—uterine cancer	0.000812	0.0112	CbGeAlD
Nifedipine—CALM3—smooth muscle tissue—uterine cancer	0.00079	0.0109	CbGeAlD
Nifedipine—CALM3—decidua—uterine cancer	0.000774	0.0107	CbGeAlD
Nifedipine—CACNA2D1—female gonad—uterine cancer	0.00077	0.0106	CbGeAlD
Nifedipine—CACNA2D1—vagina—uterine cancer	0.000765	0.0106	CbGeAlD
Nifedipine—CALM3—endometrium—uterine cancer	0.000735	0.0101	CbGeAlD
Nifedipine—CACNA1C—female reproductive system—uterine cancer	0.000727	0.01	CbGeAlD
Nifedipine—CALM3—mammalian vulva—uterine cancer	0.000711	0.00982	CbGeAlD
Nifedipine—CALM3—uterus—uterine cancer	0.000677	0.00935	CbGeAlD
Nifedipine—ABCC3—female reproductive system—uterine cancer	0.000661	0.00913	CbGeAlD
Nifedipine—ABCC2—renal system—uterine cancer	0.00066	0.00911	CbGeAlD
Nifedipine—CACNA1C—vagina—uterine cancer	0.000657	0.00908	CbGeAlD
Nifedipine—CALM2—epithelium—uterine cancer	0.000643	0.00889	CbGeAlD
Nifedipine—CALM1—epithelium—uterine cancer	0.000641	0.00885	CbGeAlD
Nifedipine—CYP2A6—vagina—uterine cancer	0.000638	0.00882	CbGeAlD
Nifedipine—CALM2—uterine cervix—uterine cancer	0.000638	0.00881	CbGeAlD
Nifedipine—CALM1—uterine cervix—uterine cancer	0.000635	0.00877	CbGeAlD
Nifedipine—CALM2—smooth muscle tissue—uterine cancer	0.00062	0.00856	CbGeAlD
Nifedipine—CALM1—smooth muscle tissue—uterine cancer	0.000617	0.00852	CbGeAlD
Nifedipine—CALM2—decidua—uterine cancer	0.000608	0.0084	CbGeAlD
Nifedipine—CALM1—decidua—uterine cancer	0.000605	0.00836	CbGeAlD
Nifedipine—ABCC3—female gonad—uterine cancer	0.000602	0.00831	CbGeAlD
Nifedipine—CALM2—renal system—uterine cancer	0.000597	0.00824	CbGeAlD
Nifedipine—CALM1—renal system—uterine cancer	0.000594	0.00821	CbGeAlD
Nifedipine—CALM2—endometrium—uterine cancer	0.000577	0.00797	CbGeAlD
Nifedipine—CALM1—endometrium—uterine cancer	0.000574	0.00793	CbGeAlD
Nifedipine—CALM2—mammalian vulva—uterine cancer	0.000558	0.00771	CbGeAlD
Nifedipine—CACNA1H—lymph node—uterine cancer	0.000558	0.00771	CbGeAlD
Nifedipine—CALM1—mammalian vulva—uterine cancer	0.000556	0.00767	CbGeAlD
Nifedipine—CALM3—female gonad—uterine cancer	0.000554	0.00765	CbGeAlD
Nifedipine—CALM3—vagina—uterine cancer	0.000551	0.0076	CbGeAlD
Nifedipine—CALM2—uterus—uterine cancer	0.000532	0.00734	CbGeAlD
Nifedipine—CALM1—uterus—uterine cancer	0.000529	0.00731	CbGeAlD
Nifedipine—ABCC2—female reproductive system—uterine cancer	0.000528	0.0073	CbGeAlD
Nifedipine—CACNB2—lymph node—uterine cancer	0.000527	0.00728	CbGeAlD
Nifedipine—CACNA2D1—lymph node—uterine cancer	0.000495	0.00683	CbGeAlD
Nifedipine—CYP2C8—renal system—uterine cancer	0.000495	0.00683	CbGeAlD
Nifedipine—CYP1A1—epithelium—uterine cancer	0.000492	0.0068	CbGeAlD
Nifedipine—CYP1A1—uterine cervix—uterine cancer	0.000488	0.00674	CbGeAlD
Nifedipine—CYP2C8—endometrium—uterine cancer	0.000478	0.00661	CbGeAlD
Nifedipine—CALM2—female reproductive system—uterine cancer	0.000478	0.0066	CbGeAlD
Nifedipine—CYP3A5—uterine cervix—uterine cancer	0.000477	0.00659	CbGeAlD
Nifedipine—CALM1—female reproductive system—uterine cancer	0.000476	0.00657	CbGeAlD
Nifedipine—CYP1A2—renal system—uterine cancer	0.000463	0.00639	CbGeAlD
Nifedipine—CACNA1D—lymph node—uterine cancer	0.000461	0.00636	CbGeAlD
Nifedipine—CYP1A1—renal system—uterine cancer	0.000457	0.00631	CbGeAlD
Nifedipine—CYP3A5—renal system—uterine cancer	0.000446	0.00617	CbGeAlD
Nifedipine—CYP2B6—renal system—uterine cancer	0.000444	0.00613	CbGeAlD
Nifedipine—CALM2—female gonad—uterine cancer	0.000435	0.00601	CbGeAlD
Nifedipine—CALM1—female gonad—uterine cancer	0.000433	0.00598	CbGeAlD
Nifedipine—CALM2—vagina—uterine cancer	0.000432	0.00597	CbGeAlD
Nifedipine—CALM1—vagina—uterine cancer	0.00043	0.00594	CbGeAlD
Nifedipine—CYP1A1—mammalian vulva—uterine cancer	0.000427	0.0059	CbGeAlD
Nifedipine—CACNA1C—lymph node—uterine cancer	0.000425	0.00587	CbGeAlD
Nifedipine—CYP2E1—renal system—uterine cancer	0.000416	0.00575	CbGeAlD
Nifedipine—CYP1A1—uterus—uterine cancer	0.000407	0.00562	CbGeAlD
Nifedipine—CYP2C8—female reproductive system—uterine cancer	0.000396	0.00547	CbGeAlD
Nifedipine—ABCC3—lymph node—uterine cancer	0.000387	0.00534	CbGeAlD
Nifedipine—CYP1A1—female reproductive system—uterine cancer	0.000366	0.00505	CbGeAlD
Nifedipine—CYP2C8—vagina—uterine cancer	0.000358	0.00495	CbGeAlD
Nifedipine—CALM3—lymph node—uterine cancer	0.000356	0.00492	CbGeAlD
Nifedipine—CYP2B6—female reproductive system—uterine cancer	0.000355	0.00491	CbGeAlD
Nifedipine—CYP2C9—female reproductive system—uterine cancer	0.000352	0.00486	CbGeAlD
Nifedipine—CYP3A4—renal system—uterine cancer	0.000335	0.00463	CbGeAlD
Nifedipine—CYP2E1—female reproductive system—uterine cancer	0.000333	0.00461	CbGeAlD
Nifedipine—CYP1A1—female gonad—uterine cancer	0.000333	0.0046	CbGeAlD
Nifedipine—CYP1A1—vagina—uterine cancer	0.000331	0.00457	CbGeAlD
Nifedipine—CYP2D6—renal system—uterine cancer	0.00033	0.00455	CbGeAlD
Nifedipine—ABCB1—myometrium—uterine cancer	0.000326	0.0045	CbGeAlD
Nifedipine—CYP3A5—female gonad—uterine cancer	0.000325	0.00449	CbGeAlD
Nifedipine—CYP3A5—vagina—uterine cancer	0.000323	0.00447	CbGeAlD
Nifedipine—CYP2B6—vagina—uterine cancer	0.000321	0.00444	CbGeAlD
Nifedipine—ABCC2—lymph node—uterine cancer	0.000309	0.00427	CbGeAlD
Nifedipine—CALM2—lymph node—uterine cancer	0.00028	0.00386	CbGeAlD
Nifedipine—CALM1—lymph node—uterine cancer	0.000278	0.00384	CbGeAlD
Nifedipine—CYP3A4—female reproductive system—uterine cancer	0.000268	0.00371	CbGeAlD
Nifedipine—CYP2D6—female reproductive system—uterine cancer	0.000264	0.00365	CbGeAlD
Nifedipine—ABCB1—epithelium—uterine cancer	0.000256	0.00353	CbGeAlD
Nifedipine—ABCB1—uterine cervix—uterine cancer	0.000254	0.0035	CbGeAlD
Nifedipine—ABCB1—decidua—uterine cancer	0.000242	0.00334	CbGeAlD
Nifedipine—CYP2D6—female gonad—uterine cancer	0.00024	0.00332	CbGeAlD
Nifedipine—ABCB1—renal system—uterine cancer	0.000237	0.00328	CbGeAlD
Nifedipine—ABCB1—endometrium—uterine cancer	0.000229	0.00317	CbGeAlD
Nifedipine—ABCB1—mammalian vulva—uterine cancer	0.000222	0.00306	CbGeAlD
Nifedipine—CYP1A1—lymph node—uterine cancer	0.000214	0.00295	CbGeAlD
Nifedipine—ABCB1—uterus—uterine cancer	0.000211	0.00292	CbGeAlD
Nifedipine—ABCB1—female reproductive system—uterine cancer	0.00019	0.00262	CbGeAlD
Nifedipine—ABCB1—female gonad—uterine cancer	0.000173	0.00239	CbGeAlD
Nifedipine—ABCB1—vagina—uterine cancer	0.000172	0.00237	CbGeAlD
Nifedipine—Tachycardia—Etoposide—uterine cancer	0.000133	0.000709	CcSEcCtD
Nifedipine—Eosinophilia—Epirubicin—uterine cancer	0.000133	0.000709	CcSEcCtD
Nifedipine—Liver function test abnormal—Doxorubicin—uterine cancer	0.000133	0.000708	CcSEcCtD
Nifedipine—Skin disorder—Etoposide—uterine cancer	0.000132	0.000706	CcSEcCtD
Nifedipine—Hyperhidrosis—Etoposide—uterine cancer	0.000132	0.000702	CcSEcCtD
Nifedipine—Orthostatic hypotension—Doxorubicin—uterine cancer	0.000131	0.0007	CcSEcCtD
Nifedipine—Angina pectoris—Epirubicin—uterine cancer	0.000131	0.000698	CcSEcCtD
Nifedipine—Breast disorder—Doxorubicin—uterine cancer	0.00013	0.000693	CcSEcCtD
Nifedipine—Anorexia—Etoposide—uterine cancer	0.00013	0.000693	CcSEcCtD
Nifedipine—Toxic epidermal necrolysis—Doxorubicin—uterine cancer	0.00013	0.00069	CcSEcCtD
Nifedipine—Diarrhoea—Dactinomycin—uterine cancer	0.000129	0.000687	CcSEcCtD
Nifedipine—Hypotension—Etoposide—uterine cancer	0.000127	0.000679	CcSEcCtD
Nifedipine—Muscular weakness—Doxorubicin—uterine cancer	0.000127	0.000676	CcSEcCtD
Nifedipine—Alanine aminotransferase increased—Doxorubicin—uterine cancer	0.000127	0.000676	CcSEcCtD
Nifedipine—Dysuria—Epirubicin—uterine cancer	0.000126	0.00067	CcSEcCtD
Nifedipine—Abdominal distension—Doxorubicin—uterine cancer	0.000125	0.000667	CcSEcCtD
Nifedipine—Upper respiratory tract infection—Epirubicin—uterine cancer	0.000125	0.000666	CcSEcCtD
Nifedipine—Dysphagia—Doxorubicin—uterine cancer	0.000124	0.000663	CcSEcCtD
Nifedipine—Pollakiuria—Epirubicin—uterine cancer	0.000124	0.000662	CcSEcCtD
Nifedipine—Eosinophilia—Doxorubicin—uterine cancer	0.000123	0.000656	CcSEcCtD
Nifedipine—Photosensitivity reaction—Epirubicin—uterine cancer	0.000123	0.000654	CcSEcCtD
Nifedipine—Paraesthesia—Etoposide—uterine cancer	0.000122	0.000652	CcSEcCtD
Nifedipine—Weight increased—Epirubicin—uterine cancer	0.000122	0.000652	CcSEcCtD
Nifedipine—Weight decreased—Epirubicin—uterine cancer	0.000122	0.000648	CcSEcCtD
Nifedipine—Dyspnoea—Etoposide—uterine cancer	0.000122	0.000648	CcSEcCtD
Nifedipine—Hyperglycaemia—Epirubicin—uterine cancer	0.000121	0.000646	CcSEcCtD
Nifedipine—Somnolence—Etoposide—uterine cancer	0.000121	0.000646	CcSEcCtD
Nifedipine—Angina pectoris—Doxorubicin—uterine cancer	0.000121	0.000645	CcSEcCtD
Nifedipine—Vomiting—Dactinomycin—uterine cancer	0.00012	0.000638	CcSEcCtD
Nifedipine—Stevens-Johnson syndrome—Epirubicin—uterine cancer	0.000119	0.000633	CcSEcCtD
Nifedipine—Rash—Dactinomycin—uterine cancer	0.000119	0.000633	CcSEcCtD
Nifedipine—Decreased appetite—Etoposide—uterine cancer	0.000119	0.000632	CcSEcCtD
Nifedipine—Gastrointestinal disorder—Etoposide—uterine cancer	0.000118	0.000627	CcSEcCtD
Nifedipine—Fatigue—Etoposide—uterine cancer	0.000118	0.000626	CcSEcCtD
Nifedipine—Jaundice—Epirubicin—uterine cancer	0.000117	0.000622	CcSEcCtD
Nifedipine—Constipation—Etoposide—uterine cancer	0.000117	0.000621	CcSEcCtD
Nifedipine—Pain—Etoposide—uterine cancer	0.000117	0.000621	CcSEcCtD
Nifedipine—Conjunctivitis—Epirubicin—uterine cancer	0.000117	0.000621	CcSEcCtD
Nifedipine—Dysuria—Doxorubicin—uterine cancer	0.000116	0.00062	CcSEcCtD
Nifedipine—Upper respiratory tract infection—Doxorubicin—uterine cancer	0.000116	0.000616	CcSEcCtD
Nifedipine—Sweating—Epirubicin—uterine cancer	0.000115	0.000612	CcSEcCtD
Nifedipine—Pollakiuria—Doxorubicin—uterine cancer	0.000115	0.000612	CcSEcCtD
Nifedipine—Haematuria—Epirubicin—uterine cancer	0.000114	0.000609	CcSEcCtD
Nifedipine—Photosensitivity reaction—Doxorubicin—uterine cancer	0.000114	0.000605	CcSEcCtD
Nifedipine—Hepatobiliary disease—Epirubicin—uterine cancer	0.000113	0.000604	CcSEcCtD
Nifedipine—Weight increased—Doxorubicin—uterine cancer	0.000113	0.000603	CcSEcCtD
Nifedipine—Epistaxis—Epirubicin—uterine cancer	0.000113	0.000602	CcSEcCtD
Nifedipine—Weight decreased—Doxorubicin—uterine cancer	0.000113	0.0006	CcSEcCtD
Nifedipine—Sinusitis—Epirubicin—uterine cancer	0.000112	0.000599	CcSEcCtD
Nifedipine—Feeling abnormal—Etoposide—uterine cancer	0.000112	0.000599	CcSEcCtD
Nifedipine—Hyperglycaemia—Doxorubicin—uterine cancer	0.000112	0.000598	CcSEcCtD
Nifedipine—Nausea—Dactinomycin—uterine cancer	0.000112	0.000596	CcSEcCtD
Nifedipine—Agranulocytosis—Epirubicin—uterine cancer	0.000112	0.000596	CcSEcCtD
Nifedipine—Gastrointestinal pain—Etoposide—uterine cancer	0.000112	0.000594	CcSEcCtD
Nifedipine—ABCB1—lymph node—uterine cancer	0.000111	0.00153	CbGeAlD
Nifedipine—Stevens-Johnson syndrome—Doxorubicin—uterine cancer	0.00011	0.000586	CcSEcCtD
Nifedipine—Bradycardia—Epirubicin—uterine cancer	0.00011	0.000584	CcSEcCtD
Nifedipine—Urticaria—Etoposide—uterine cancer	0.000108	0.000577	CcSEcCtD
Nifedipine—Haemoglobin—Epirubicin—uterine cancer	0.000108	0.000576	CcSEcCtD
Nifedipine—Jaundice—Doxorubicin—uterine cancer	0.000108	0.000576	CcSEcCtD
Nifedipine—Rhinitis—Epirubicin—uterine cancer	0.000108	0.000575	CcSEcCtD
Nifedipine—Abdominal pain—Etoposide—uterine cancer	0.000108	0.000574	CcSEcCtD
Nifedipine—Body temperature increased—Etoposide—uterine cancer	0.000108	0.000574	CcSEcCtD
Nifedipine—Conjunctivitis—Doxorubicin—uterine cancer	0.000108	0.000574	CcSEcCtD
Nifedipine—Hepatitis—Epirubicin—uterine cancer	0.000108	0.000573	CcSEcCtD
Nifedipine—Haemorrhage—Epirubicin—uterine cancer	0.000108	0.000573	CcSEcCtD
Nifedipine—Hypoaesthesia—Epirubicin—uterine cancer	0.000107	0.00057	CcSEcCtD
Nifedipine—Pharyngitis—Epirubicin—uterine cancer	0.000107	0.000569	CcSEcCtD
Nifedipine—Sweating—Doxorubicin—uterine cancer	0.000106	0.000566	CcSEcCtD
Nifedipine—Urinary tract disorder—Epirubicin—uterine cancer	0.000106	0.000566	CcSEcCtD
Nifedipine—Oedema peripheral—Epirubicin—uterine cancer	0.000106	0.000565	CcSEcCtD
Nifedipine—Haematuria—Doxorubicin—uterine cancer	0.000106	0.000563	CcSEcCtD
Nifedipine—Connective tissue disorder—Epirubicin—uterine cancer	0.000106	0.000563	CcSEcCtD
Nifedipine—Urethral disorder—Epirubicin—uterine cancer	0.000105	0.000562	CcSEcCtD
Nifedipine—Hepatobiliary disease—Doxorubicin—uterine cancer	0.000105	0.000559	CcSEcCtD
Nifedipine—Epistaxis—Doxorubicin—uterine cancer	0.000105	0.000557	CcSEcCtD
Nifedipine—Sinusitis—Doxorubicin—uterine cancer	0.000104	0.000554	CcSEcCtD
Nifedipine—Visual impairment—Epirubicin—uterine cancer	0.000104	0.000552	CcSEcCtD
Nifedipine—Agranulocytosis—Doxorubicin—uterine cancer	0.000104	0.000551	CcSEcCtD
Nifedipine—Erythema multiforme—Epirubicin—uterine cancer	0.000102	0.000542	CcSEcCtD
Nifedipine—Bradycardia—Doxorubicin—uterine cancer	0.000101	0.00054	CcSEcCtD
Nifedipine—Eye disorder—Epirubicin—uterine cancer	0.000101	0.000536	CcSEcCtD
Nifedipine—Hypersensitivity—Etoposide—uterine cancer	0.0001	0.000535	CcSEcCtD
Nifedipine—Tinnitus—Epirubicin—uterine cancer	0.0001	0.000534	CcSEcCtD
Nifedipine—Haemoglobin—Doxorubicin—uterine cancer	0.0001	0.000533	CcSEcCtD
Nifedipine—Flushing—Epirubicin—uterine cancer	9.99e-05	0.000532	CcSEcCtD
Nifedipine—Cardiac disorder—Epirubicin—uterine cancer	9.99e-05	0.000532	CcSEcCtD
Nifedipine—Rhinitis—Doxorubicin—uterine cancer	9.98e-05	0.000532	CcSEcCtD
Nifedipine—Haemorrhage—Doxorubicin—uterine cancer	9.96e-05	0.00053	CcSEcCtD
Nifedipine—Hepatitis—Doxorubicin—uterine cancer	9.96e-05	0.00053	CcSEcCtD
Nifedipine—Hypoaesthesia—Doxorubicin—uterine cancer	9.91e-05	0.000528	CcSEcCtD
Nifedipine—Pharyngitis—Doxorubicin—uterine cancer	9.88e-05	0.000526	CcSEcCtD
Nifedipine—Urinary tract disorder—Doxorubicin—uterine cancer	9.83e-05	0.000524	CcSEcCtD
Nifedipine—Oedema peripheral—Doxorubicin—uterine cancer	9.81e-05	0.000523	CcSEcCtD
Nifedipine—Asthenia—Etoposide—uterine cancer	9.79e-05	0.000521	CcSEcCtD
Nifedipine—Connective tissue disorder—Doxorubicin—uterine cancer	9.79e-05	0.000521	CcSEcCtD
Nifedipine—Angiopathy—Epirubicin—uterine cancer	9.76e-05	0.00052	CcSEcCtD
Nifedipine—Urethral disorder—Doxorubicin—uterine cancer	9.76e-05	0.00052	CcSEcCtD
Nifedipine—Immune system disorder—Epirubicin—uterine cancer	9.72e-05	0.000518	CcSEcCtD
Nifedipine—Mediastinal disorder—Epirubicin—uterine cancer	9.7e-05	0.000517	CcSEcCtD
Nifedipine—Chills—Epirubicin—uterine cancer	9.66e-05	0.000514	CcSEcCtD
Nifedipine—Pruritus—Etoposide—uterine cancer	9.65e-05	0.000514	CcSEcCtD
Nifedipine—Arrhythmia—Epirubicin—uterine cancer	9.61e-05	0.000512	CcSEcCtD
Nifedipine—Visual impairment—Doxorubicin—uterine cancer	9.6e-05	0.000511	CcSEcCtD
Nifedipine—Alopecia—Epirubicin—uterine cancer	9.51e-05	0.000507	CcSEcCtD
Nifedipine—Mental disorder—Epirubicin—uterine cancer	9.43e-05	0.000502	CcSEcCtD
Nifedipine—Erythema multiforme—Doxorubicin—uterine cancer	9.41e-05	0.000501	CcSEcCtD
Nifedipine—Erythema—Epirubicin—uterine cancer	9.37e-05	0.000499	CcSEcCtD
Nifedipine—Malnutrition—Epirubicin—uterine cancer	9.37e-05	0.000499	CcSEcCtD
Nifedipine—Diarrhoea—Etoposide—uterine cancer	9.33e-05	0.000497	CcSEcCtD
Nifedipine—Eye disorder—Doxorubicin—uterine cancer	9.31e-05	0.000496	CcSEcCtD
Nifedipine—Tinnitus—Doxorubicin—uterine cancer	9.28e-05	0.000495	CcSEcCtD
Nifedipine—Cardiac disorder—Doxorubicin—uterine cancer	9.24e-05	0.000492	CcSEcCtD
Nifedipine—Flushing—Doxorubicin—uterine cancer	9.24e-05	0.000492	CcSEcCtD
Nifedipine—Flatulence—Epirubicin—uterine cancer	9.23e-05	0.000492	CcSEcCtD
Nifedipine—Tension—Epirubicin—uterine cancer	9.19e-05	0.00049	CcSEcCtD
Nifedipine—Dysgeusia—Epirubicin—uterine cancer	9.17e-05	0.000489	CcSEcCtD
Nifedipine—Nervousness—Epirubicin—uterine cancer	9.1e-05	0.000485	CcSEcCtD
Nifedipine—Back pain—Epirubicin—uterine cancer	9.06e-05	0.000483	CcSEcCtD
Nifedipine—Angiopathy—Doxorubicin—uterine cancer	9.03e-05	0.000481	CcSEcCtD
Nifedipine—Dizziness—Etoposide—uterine cancer	9.02e-05	0.00048	CcSEcCtD
Nifedipine—Muscle spasms—Epirubicin—uterine cancer	9.01e-05	0.00048	CcSEcCtD
Nifedipine—Immune system disorder—Doxorubicin—uterine cancer	8.99e-05	0.000479	CcSEcCtD
Nifedipine—Mediastinal disorder—Doxorubicin—uterine cancer	8.97e-05	0.000478	CcSEcCtD
Nifedipine—Chills—Doxorubicin—uterine cancer	8.93e-05	0.000476	CcSEcCtD
Nifedipine—Arrhythmia—Doxorubicin—uterine cancer	8.9e-05	0.000474	CcSEcCtD
Nifedipine—Vision blurred—Epirubicin—uterine cancer	8.83e-05	0.00047	CcSEcCtD
Nifedipine—Alopecia—Doxorubicin—uterine cancer	8.8e-05	0.000469	CcSEcCtD
Nifedipine—Mental disorder—Doxorubicin—uterine cancer	8.72e-05	0.000465	CcSEcCtD
Nifedipine—Ill-defined disorder—Epirubicin—uterine cancer	8.69e-05	0.000463	CcSEcCtD
Nifedipine—Vomiting—Etoposide—uterine cancer	8.67e-05	0.000462	CcSEcCtD
Nifedipine—Malnutrition—Doxorubicin—uterine cancer	8.67e-05	0.000462	CcSEcCtD
Nifedipine—Erythema—Doxorubicin—uterine cancer	8.67e-05	0.000462	CcSEcCtD
Nifedipine—Anaemia—Epirubicin—uterine cancer	8.66e-05	0.000461	CcSEcCtD
Nifedipine—Agitation—Epirubicin—uterine cancer	8.61e-05	0.000459	CcSEcCtD
Nifedipine—Rash—Etoposide—uterine cancer	8.6e-05	0.000458	CcSEcCtD
Nifedipine—Dermatitis—Etoposide—uterine cancer	8.59e-05	0.000458	CcSEcCtD
Nifedipine—Headache—Etoposide—uterine cancer	8.54e-05	0.000455	CcSEcCtD
Nifedipine—Flatulence—Doxorubicin—uterine cancer	8.54e-05	0.000455	CcSEcCtD
Nifedipine—Tension—Doxorubicin—uterine cancer	8.51e-05	0.000453	CcSEcCtD
Nifedipine—Dysgeusia—Doxorubicin—uterine cancer	8.49e-05	0.000452	CcSEcCtD
Nifedipine—Malaise—Epirubicin—uterine cancer	8.45e-05	0.00045	CcSEcCtD
Nifedipine—Nervousness—Doxorubicin—uterine cancer	8.42e-05	0.000448	CcSEcCtD
Nifedipine—Vertigo—Epirubicin—uterine cancer	8.42e-05	0.000448	CcSEcCtD
Nifedipine—Syncope—Epirubicin—uterine cancer	8.4e-05	0.000447	CcSEcCtD
Nifedipine—Leukopenia—Epirubicin—uterine cancer	8.39e-05	0.000447	CcSEcCtD
Nifedipine—Back pain—Doxorubicin—uterine cancer	8.38e-05	0.000447	CcSEcCtD
Nifedipine—Muscle spasms—Doxorubicin—uterine cancer	8.33e-05	0.000444	CcSEcCtD
Nifedipine—Palpitations—Epirubicin—uterine cancer	8.28e-05	0.000441	CcSEcCtD
Nifedipine—Loss of consciousness—Epirubicin—uterine cancer	8.23e-05	0.000439	CcSEcCtD
Nifedipine—Cough—Epirubicin—uterine cancer	8.17e-05	0.000435	CcSEcCtD
Nifedipine—Vision blurred—Doxorubicin—uterine cancer	8.17e-05	0.000435	CcSEcCtD
Nifedipine—Nausea—Etoposide—uterine cancer	8.1e-05	0.000432	CcSEcCtD
Nifedipine—Ill-defined disorder—Doxorubicin—uterine cancer	8.04e-05	0.000428	CcSEcCtD
Nifedipine—Anaemia—Doxorubicin—uterine cancer	8.01e-05	0.000427	CcSEcCtD
Nifedipine—Myalgia—Epirubicin—uterine cancer	7.98e-05	0.000425	CcSEcCtD
Nifedipine—Arthralgia—Epirubicin—uterine cancer	7.98e-05	0.000425	CcSEcCtD
Nifedipine—Chest pain—Epirubicin—uterine cancer	7.98e-05	0.000425	CcSEcCtD
Nifedipine—Agitation—Doxorubicin—uterine cancer	7.97e-05	0.000424	CcSEcCtD
Nifedipine—Anxiety—Epirubicin—uterine cancer	7.95e-05	0.000423	CcSEcCtD
Nifedipine—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—uterine cancer	7.92e-05	0.000422	CcSEcCtD
Nifedipine—Discomfort—Epirubicin—uterine cancer	7.88e-05	0.00042	CcSEcCtD
Nifedipine—Malaise—Doxorubicin—uterine cancer	7.82e-05	0.000416	CcSEcCtD
Nifedipine—Dry mouth—Epirubicin—uterine cancer	7.8e-05	0.000415	CcSEcCtD
Nifedipine—Vertigo—Doxorubicin—uterine cancer	7.79e-05	0.000415	CcSEcCtD
Nifedipine—Syncope—Doxorubicin—uterine cancer	7.77e-05	0.000414	CcSEcCtD
Nifedipine—Leukopenia—Doxorubicin—uterine cancer	7.76e-05	0.000413	CcSEcCtD
Nifedipine—Confusional state—Epirubicin—uterine cancer	7.71e-05	0.000411	CcSEcCtD
Nifedipine—Palpitations—Doxorubicin—uterine cancer	7.66e-05	0.000408	CcSEcCtD
Nifedipine—Anaphylactic shock—Epirubicin—uterine cancer	7.65e-05	0.000407	CcSEcCtD
Nifedipine—Oedema—Epirubicin—uterine cancer	7.65e-05	0.000407	CcSEcCtD
Nifedipine—Loss of consciousness—Doxorubicin—uterine cancer	7.62e-05	0.000406	CcSEcCtD
Nifedipine—Cough—Doxorubicin—uterine cancer	7.56e-05	0.000403	CcSEcCtD
Nifedipine—Shock—Epirubicin—uterine cancer	7.52e-05	0.000401	CcSEcCtD
Nifedipine—Nervous system disorder—Epirubicin—uterine cancer	7.5e-05	0.000399	CcSEcCtD
Nifedipine—Thrombocytopenia—Epirubicin—uterine cancer	7.49e-05	0.000399	CcSEcCtD
Nifedipine—Tachycardia—Epirubicin—uterine cancer	7.46e-05	0.000397	CcSEcCtD
Nifedipine—Skin disorder—Epirubicin—uterine cancer	7.43e-05	0.000396	CcSEcCtD
Nifedipine—Hyperhidrosis—Epirubicin—uterine cancer	7.39e-05	0.000394	CcSEcCtD
Nifedipine—Arthralgia—Doxorubicin—uterine cancer	7.38e-05	0.000393	CcSEcCtD
Nifedipine—Myalgia—Doxorubicin—uterine cancer	7.38e-05	0.000393	CcSEcCtD
Nifedipine—Chest pain—Doxorubicin—uterine cancer	7.38e-05	0.000393	CcSEcCtD
Nifedipine—Anxiety—Doxorubicin—uterine cancer	7.35e-05	0.000392	CcSEcCtD
Nifedipine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—uterine cancer	7.33e-05	0.00039	CcSEcCtD
Nifedipine—Discomfort—Doxorubicin—uterine cancer	7.29e-05	0.000388	CcSEcCtD
Nifedipine—Anorexia—Epirubicin—uterine cancer	7.29e-05	0.000388	CcSEcCtD
Nifedipine—Dry mouth—Doxorubicin—uterine cancer	7.22e-05	0.000384	CcSEcCtD
Nifedipine—Hypotension—Epirubicin—uterine cancer	7.14e-05	0.000381	CcSEcCtD
Nifedipine—Confusional state—Doxorubicin—uterine cancer	7.13e-05	0.00038	CcSEcCtD
Nifedipine—Oedema—Doxorubicin—uterine cancer	7.07e-05	0.000377	CcSEcCtD
Nifedipine—Anaphylactic shock—Doxorubicin—uterine cancer	7.07e-05	0.000377	CcSEcCtD
Nifedipine—Musculoskeletal discomfort—Epirubicin—uterine cancer	6.97e-05	0.000371	CcSEcCtD
Nifedipine—Shock—Doxorubicin—uterine cancer	6.96e-05	0.000371	CcSEcCtD
Nifedipine—Nervous system disorder—Doxorubicin—uterine cancer	6.94e-05	0.00037	CcSEcCtD
Nifedipine—Thrombocytopenia—Doxorubicin—uterine cancer	6.93e-05	0.000369	CcSEcCtD
Nifedipine—Insomnia—Epirubicin—uterine cancer	6.92e-05	0.000368	CcSEcCtD
Nifedipine—Tachycardia—Doxorubicin—uterine cancer	6.9e-05	0.000368	CcSEcCtD
Nifedipine—Skin disorder—Doxorubicin—uterine cancer	6.87e-05	0.000366	CcSEcCtD
Nifedipine—Paraesthesia—Epirubicin—uterine cancer	6.87e-05	0.000366	CcSEcCtD
Nifedipine—Hyperhidrosis—Doxorubicin—uterine cancer	6.84e-05	0.000364	CcSEcCtD
Nifedipine—Dyspnoea—Epirubicin—uterine cancer	6.82e-05	0.000363	CcSEcCtD
Nifedipine—Somnolence—Epirubicin—uterine cancer	6.8e-05	0.000362	CcSEcCtD
Nifedipine—Anorexia—Doxorubicin—uterine cancer	6.74e-05	0.000359	CcSEcCtD
Nifedipine—Dyspepsia—Epirubicin—uterine cancer	6.73e-05	0.000358	CcSEcCtD
Nifedipine—Decreased appetite—Epirubicin—uterine cancer	6.65e-05	0.000354	CcSEcCtD
Nifedipine—Hypotension—Doxorubicin—uterine cancer	6.61e-05	0.000352	CcSEcCtD
Nifedipine—Gastrointestinal disorder—Epirubicin—uterine cancer	6.6e-05	0.000352	CcSEcCtD
Nifedipine—Fatigue—Epirubicin—uterine cancer	6.59e-05	0.000351	CcSEcCtD
Nifedipine—Constipation—Epirubicin—uterine cancer	6.54e-05	0.000348	CcSEcCtD
Nifedipine—Pain—Epirubicin—uterine cancer	6.54e-05	0.000348	CcSEcCtD
Nifedipine—Musculoskeletal discomfort—Doxorubicin—uterine cancer	6.45e-05	0.000343	CcSEcCtD
Nifedipine—Insomnia—Doxorubicin—uterine cancer	6.4e-05	0.000341	CcSEcCtD
Nifedipine—Paraesthesia—Doxorubicin—uterine cancer	6.35e-05	0.000338	CcSEcCtD
Nifedipine—Dyspnoea—Doxorubicin—uterine cancer	6.31e-05	0.000336	CcSEcCtD
Nifedipine—Feeling abnormal—Epirubicin—uterine cancer	6.3e-05	0.000336	CcSEcCtD
Nifedipine—Somnolence—Doxorubicin—uterine cancer	6.29e-05	0.000335	CcSEcCtD
Nifedipine—Gastrointestinal pain—Epirubicin—uterine cancer	6.25e-05	0.000333	CcSEcCtD
Nifedipine—Dyspepsia—Doxorubicin—uterine cancer	6.23e-05	0.000332	CcSEcCtD
Nifedipine—Decreased appetite—Doxorubicin—uterine cancer	6.15e-05	0.000328	CcSEcCtD
Nifedipine—Gastrointestinal disorder—Doxorubicin—uterine cancer	6.11e-05	0.000325	CcSEcCtD
Nifedipine—Fatigue—Doxorubicin—uterine cancer	6.1e-05	0.000325	CcSEcCtD
Nifedipine—Urticaria—Epirubicin—uterine cancer	6.07e-05	0.000324	CcSEcCtD
Nifedipine—Constipation—Doxorubicin—uterine cancer	6.05e-05	0.000322	CcSEcCtD
Nifedipine—Pain—Doxorubicin—uterine cancer	6.05e-05	0.000322	CcSEcCtD
Nifedipine—Abdominal pain—Epirubicin—uterine cancer	6.04e-05	0.000322	CcSEcCtD
Nifedipine—Body temperature increased—Epirubicin—uterine cancer	6.04e-05	0.000322	CcSEcCtD
Nifedipine—Feeling abnormal—Doxorubicin—uterine cancer	5.83e-05	0.000311	CcSEcCtD
Nifedipine—Gastrointestinal pain—Doxorubicin—uterine cancer	5.78e-05	0.000308	CcSEcCtD
Nifedipine—Hypersensitivity—Epirubicin—uterine cancer	5.63e-05	0.0003	CcSEcCtD
Nifedipine—Urticaria—Doxorubicin—uterine cancer	5.62e-05	0.000299	CcSEcCtD
Nifedipine—Abdominal pain—Doxorubicin—uterine cancer	5.59e-05	0.000298	CcSEcCtD
Nifedipine—Body temperature increased—Doxorubicin—uterine cancer	5.59e-05	0.000298	CcSEcCtD
Nifedipine—Asthenia—Epirubicin—uterine cancer	5.49e-05	0.000292	CcSEcCtD
Nifedipine—Pruritus—Epirubicin—uterine cancer	5.41e-05	0.000288	CcSEcCtD
Nifedipine—Diarrhoea—Epirubicin—uterine cancer	5.23e-05	0.000279	CcSEcCtD
Nifedipine—Hypersensitivity—Doxorubicin—uterine cancer	5.21e-05	0.000278	CcSEcCtD
Nifedipine—Asthenia—Doxorubicin—uterine cancer	5.08e-05	0.00027	CcSEcCtD
Nifedipine—Dizziness—Epirubicin—uterine cancer	5.06e-05	0.000269	CcSEcCtD
Nifedipine—Pruritus—Doxorubicin—uterine cancer	5.01e-05	0.000267	CcSEcCtD
Nifedipine—Vomiting—Epirubicin—uterine cancer	4.86e-05	0.000259	CcSEcCtD
Nifedipine—Diarrhoea—Doxorubicin—uterine cancer	4.84e-05	0.000258	CcSEcCtD
Nifedipine—Rash—Epirubicin—uterine cancer	4.82e-05	0.000257	CcSEcCtD
Nifedipine—Dermatitis—Epirubicin—uterine cancer	4.82e-05	0.000257	CcSEcCtD
Nifedipine—Headache—Epirubicin—uterine cancer	4.79e-05	0.000255	CcSEcCtD
Nifedipine—Dizziness—Doxorubicin—uterine cancer	4.68e-05	0.000249	CcSEcCtD
Nifedipine—Nausea—Epirubicin—uterine cancer	4.54e-05	0.000242	CcSEcCtD
Nifedipine—Vomiting—Doxorubicin—uterine cancer	4.5e-05	0.00024	CcSEcCtD
Nifedipine—Rash—Doxorubicin—uterine cancer	4.46e-05	0.000238	CcSEcCtD
Nifedipine—Dermatitis—Doxorubicin—uterine cancer	4.46e-05	0.000237	CcSEcCtD
Nifedipine—Headache—Doxorubicin—uterine cancer	4.43e-05	0.000236	CcSEcCtD
Nifedipine—Nausea—Doxorubicin—uterine cancer	4.2e-05	0.000224	CcSEcCtD
Nifedipine—CALM1—Hemostasis—PIK3CA—uterine cancer	6.9e-06	7.3e-05	CbGpPWpGaD
Nifedipine—CALM2—Hemostasis—PIK3CA—uterine cancer	6.9e-06	7.3e-05	CbGpPWpGaD
Nifedipine—CYP3A4—Metabolism—RRM2—uterine cancer	6.81e-06	7.2e-05	CbGpPWpGaD
Nifedipine—CALM2—Innate Immune System—KRAS—uterine cancer	6.77e-06	7.15e-05	CbGpPWpGaD
Nifedipine—CALM1—Innate Immune System—KRAS—uterine cancer	6.77e-06	7.15e-05	CbGpPWpGaD
Nifedipine—CALM3—Adaptive Immune System—KRAS—uterine cancer	6.72e-06	7.1e-05	CbGpPWpGaD
Nifedipine—CALM3—Signaling Pathways—SMAD3—uterine cancer	6.72e-06	7.1e-05	CbGpPWpGaD
Nifedipine—CALM2—Hemostasis—TP53—uterine cancer	6.68e-06	7.06e-05	CbGpPWpGaD
Nifedipine—CALM1—Hemostasis—TP53—uterine cancer	6.68e-06	7.06e-05	CbGpPWpGaD
Nifedipine—CYP3A4—Metabolism—DCN—uterine cancer	6.61e-06	6.99e-05	CbGpPWpGaD
Nifedipine—CALM3—Hemostasis—HRAS—uterine cancer	6.6e-06	6.98e-05	CbGpPWpGaD
Nifedipine—CACNA1C—Metabolism—PIK3CA—uterine cancer	6.57e-06	6.94e-05	CbGpPWpGaD
Nifedipine—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	6.52e-06	6.89e-05	CbGpPWpGaD
Nifedipine—CALM2—Adaptive Immune System—KRAS—uterine cancer	6.5e-06	6.87e-05	CbGpPWpGaD
Nifedipine—CALM1—Adaptive Immune System—KRAS—uterine cancer	6.5e-06	6.87e-05	CbGpPWpGaD
Nifedipine—CALM2—Signaling Pathways—SMAD3—uterine cancer	6.5e-06	6.87e-05	CbGpPWpGaD
Nifedipine—CALM1—Signaling Pathways—SMAD3—uterine cancer	6.5e-06	6.87e-05	CbGpPWpGaD
Nifedipine—CALM3—Signaling by GPCR—CXCL8—uterine cancer	6.46e-06	6.83e-05	CbGpPWpGaD
Nifedipine—CACNB2—Metabolism—AKT1—uterine cancer	6.45e-06	6.82e-05	CbGpPWpGaD
Nifedipine—CALM3—Innate Immune System—PIK3CA—uterine cancer	6.43e-06	6.79e-05	CbGpPWpGaD
Nifedipine—CYP2C8—Metabolism—MTHFR—uterine cancer	6.41e-06	6.78e-05	CbGpPWpGaD
Nifedipine—CALM3—Signaling Pathways—FGFR2—uterine cancer	6.4e-06	6.77e-05	CbGpPWpGaD
Nifedipine—CALM1—Hemostasis—HRAS—uterine cancer	6.39e-06	6.75e-05	CbGpPWpGaD
Nifedipine—CALM2—Hemostasis—HRAS—uterine cancer	6.39e-06	6.75e-05	CbGpPWpGaD
Nifedipine—CALM1—Signaling by GPCR—CXCL8—uterine cancer	6.25e-06	6.6e-05	CbGpPWpGaD
Nifedipine—CALM2—Signaling by GPCR—CXCL8—uterine cancer	6.25e-06	6.6e-05	CbGpPWpGaD
Nifedipine—CYP3A4—Metabolism—CYP11A1—uterine cancer	6.23e-06	6.58e-05	CbGpPWpGaD
Nifedipine—CALM3—Immune System—ERBB2—uterine cancer	6.22e-06	6.58e-05	CbGpPWpGaD
Nifedipine—CYP2C9—Metabolism of lipids and lipoproteins—EP300—uterine cancer	6.22e-06	6.58e-05	CbGpPWpGaD
Nifedipine—CALM2—Innate Immune System—PIK3CA—uterine cancer	6.22e-06	6.57e-05	CbGpPWpGaD
Nifedipine—CALM1—Innate Immune System—PIK3CA—uterine cancer	6.22e-06	6.57e-05	CbGpPWpGaD
Nifedipine—CALM2—Signaling Pathways—FGFR2—uterine cancer	6.2e-06	6.55e-05	CbGpPWpGaD
Nifedipine—CALM1—Signaling Pathways—FGFR2—uterine cancer	6.2e-06	6.55e-05	CbGpPWpGaD
Nifedipine—CALM3—Adaptive Immune System—PIK3CA—uterine cancer	6.17e-06	6.52e-05	CbGpPWpGaD
Nifedipine—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	6.17e-06	6.52e-05	CbGpPWpGaD
Nifedipine—CACNA1D—Metabolism—AKT1—uterine cancer	6.1e-06	6.45e-05	CbGpPWpGaD
Nifedipine—CALM1—Immune System—ERBB2—uterine cancer	6.02e-06	6.36e-05	CbGpPWpGaD
Nifedipine—CALM2—Immune System—ERBB2—uterine cancer	6.02e-06	6.36e-05	CbGpPWpGaD
Nifedipine—CALM1—Adaptive Immune System—PIK3CA—uterine cancer	5.97e-06	6.31e-05	CbGpPWpGaD
Nifedipine—CALM2—Adaptive Immune System—PIK3CA—uterine cancer	5.97e-06	6.31e-05	CbGpPWpGaD
Nifedipine—CALM3—Innate Immune System—HRAS—uterine cancer	5.94e-06	6.29e-05	CbGpPWpGaD
Nifedipine—CYP1A2—Metabolism—CYP19A1—uterine cancer	5.94e-06	6.28e-05	CbGpPWpGaD
Nifedipine—CYP1A2—Metabolism—STK11—uterine cancer	5.94e-06	6.28e-05	CbGpPWpGaD
Nifedipine—ABCC3—Metabolism—PIK3CA—uterine cancer	5.88e-06	6.22e-05	CbGpPWpGaD
Nifedipine—CYP3A4—Metabolism—AKR1C3—uterine cancer	5.88e-06	6.22e-05	CbGpPWpGaD
Nifedipine—CALM3—Hemostasis—AKT1—uterine cancer	5.83e-06	6.16e-05	CbGpPWpGaD
Nifedipine—CALM3—Immune System—CDKN1B—uterine cancer	5.76e-06	6.09e-05	CbGpPWpGaD
Nifedipine—CALM1—Innate Immune System—HRAS—uterine cancer	5.75e-06	6.08e-05	CbGpPWpGaD
Nifedipine—CALM2—Innate Immune System—HRAS—uterine cancer	5.75e-06	6.08e-05	CbGpPWpGaD
Nifedipine—CALM3—Disease—ERBB2—uterine cancer	5.74e-06	6.07e-05	CbGpPWpGaD
Nifedipine—CALM3—Adaptive Immune System—HRAS—uterine cancer	5.71e-06	6.04e-05	CbGpPWpGaD
Nifedipine—CYP3A7—Metabolism—PTEN—uterine cancer	5.7e-06	6.03e-05	CbGpPWpGaD
Nifedipine—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	5.65e-06	5.98e-05	CbGpPWpGaD
Nifedipine—CALM1—Hemostasis—AKT1—uterine cancer	5.64e-06	5.96e-05	CbGpPWpGaD
Nifedipine—CALM2—Hemostasis—AKT1—uterine cancer	5.64e-06	5.96e-05	CbGpPWpGaD
Nifedipine—ABCB1—Metabolism—MTHFR—uterine cancer	5.59e-06	5.91e-05	CbGpPWpGaD
Nifedipine—CALM2—Immune System—CDKN1B—uterine cancer	5.57e-06	5.89e-05	CbGpPWpGaD
Nifedipine—CALM1—Immune System—CDKN1B—uterine cancer	5.57e-06	5.89e-05	CbGpPWpGaD
Nifedipine—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	5.57e-06	5.89e-05	CbGpPWpGaD
Nifedipine—CALM2—Disease—ERBB2—uterine cancer	5.56e-06	5.87e-05	CbGpPWpGaD
Nifedipine—CALM1—Disease—ERBB2—uterine cancer	5.56e-06	5.87e-05	CbGpPWpGaD
Nifedipine—CALM2—Adaptive Immune System—HRAS—uterine cancer	5.52e-06	5.84e-05	CbGpPWpGaD
Nifedipine—CALM1—Adaptive Immune System—HRAS—uterine cancer	5.52e-06	5.84e-05	CbGpPWpGaD
Nifedipine—CALM3—Signaling Pathways—ESR1—uterine cancer	5.48e-06	5.79e-05	CbGpPWpGaD
Nifedipine—CALM3—Immune System—CTNNB1—uterine cancer	5.44e-06	5.75e-05	CbGpPWpGaD
Nifedipine—CYP3A7—Metabolism—EP300—uterine cancer	5.43e-06	5.75e-05	CbGpPWpGaD
Nifedipine—CACNA1C—Metabolism—AKT1—uterine cancer	5.36e-06	5.67e-05	CbGpPWpGaD
Nifedipine—CALM3—Disease—CDKN1B—uterine cancer	5.32e-06	5.62e-05	CbGpPWpGaD
Nifedipine—CYP1A2—Metabolism of lipids and lipoproteins—EP300—uterine cancer	5.31e-06	5.62e-05	CbGpPWpGaD
Nifedipine—CALM3—Immune System—PTEN—uterine cancer	5.3e-06	5.61e-05	CbGpPWpGaD
Nifedipine—CALM1—Signaling Pathways—ESR1—uterine cancer	5.3e-06	5.6e-05	CbGpPWpGaD
Nifedipine—CALM2—Signaling Pathways—ESR1—uterine cancer	5.3e-06	5.6e-05	CbGpPWpGaD
Nifedipine—CYP2D6—Metabolism—MTHFR—uterine cancer	5.27e-06	5.57e-05	CbGpPWpGaD
Nifedipine—CALM2—Immune System—CTNNB1—uterine cancer	5.26e-06	5.57e-05	CbGpPWpGaD
Nifedipine—CALM1—Immune System—CTNNB1—uterine cancer	5.26e-06	5.57e-05	CbGpPWpGaD
Nifedipine—CALM3—Innate Immune System—AKT1—uterine cancer	5.25e-06	5.55e-05	CbGpPWpGaD
Nifedipine—CYP2A6—Metabolism—PTEN—uterine cancer	5.22e-06	5.52e-05	CbGpPWpGaD
Nifedipine—CYP2C9—Metabolism—MTHFR—uterine cancer	5.22e-06	5.52e-05	CbGpPWpGaD
Nifedipine—CALM3—Signaling by GPCR—NRAS—uterine cancer	5.18e-06	5.48e-05	CbGpPWpGaD
Nifedipine—CALM2—Disease—CDKN1B—uterine cancer	5.15e-06	5.44e-05	CbGpPWpGaD
Nifedipine—CALM1—Disease—CDKN1B—uterine cancer	5.15e-06	5.44e-05	CbGpPWpGaD
Nifedipine—CALM2—Immune System—PTEN—uterine cancer	5.13e-06	5.43e-05	CbGpPWpGaD
Nifedipine—CALM1—Immune System—PTEN—uterine cancer	5.13e-06	5.43e-05	CbGpPWpGaD
Nifedipine—CALM2—Innate Immune System—AKT1—uterine cancer	5.08e-06	5.37e-05	CbGpPWpGaD
Nifedipine—CALM1—Innate Immune System—AKT1—uterine cancer	5.08e-06	5.37e-05	CbGpPWpGaD
Nifedipine—CALM3—Immune System—EP300—uterine cancer	5.06e-06	5.35e-05	CbGpPWpGaD
Nifedipine—CALM3—Adaptive Immune System—AKT1—uterine cancer	5.04e-06	5.33e-05	CbGpPWpGaD
Nifedipine—CALM3—Disease—CTNNB1—uterine cancer	5.03e-06	5.31e-05	CbGpPWpGaD
Nifedipine—CALM2—Signaling by GPCR—NRAS—uterine cancer	5.01e-06	5.3e-05	CbGpPWpGaD
Nifedipine—CALM1—Signaling by GPCR—NRAS—uterine cancer	5.01e-06	5.3e-05	CbGpPWpGaD
Nifedipine—CYP2A6—Metabolism—EP300—uterine cancer	4.98e-06	5.27e-05	CbGpPWpGaD
Nifedipine—CALM3—Disease—PTEN—uterine cancer	4.9e-06	5.18e-05	CbGpPWpGaD
Nifedipine—CALM2—Immune System—EP300—uterine cancer	4.89e-06	5.17e-05	CbGpPWpGaD
Nifedipine—CALM1—Immune System—EP300—uterine cancer	4.89e-06	5.17e-05	CbGpPWpGaD
Nifedipine—CALM2—Adaptive Immune System—AKT1—uterine cancer	4.88e-06	5.16e-05	CbGpPWpGaD
Nifedipine—CALM1—Adaptive Immune System—AKT1—uterine cancer	4.88e-06	5.16e-05	CbGpPWpGaD
Nifedipine—CALM2—Disease—CTNNB1—uterine cancer	4.86e-06	5.14e-05	CbGpPWpGaD
Nifedipine—CALM1—Disease—CTNNB1—uterine cancer	4.86e-06	5.14e-05	CbGpPWpGaD
Nifedipine—CALM3—Signaling Pathways—CCL2—uterine cancer	4.82e-06	5.1e-05	CbGpPWpGaD
Nifedipine—ABCC3—Metabolism—AKT1—uterine cancer	4.81e-06	5.08e-05	CbGpPWpGaD
Nifedipine—CALM1—Disease—PTEN—uterine cancer	4.74e-06	5.01e-05	CbGpPWpGaD
Nifedipine—CALM2—Disease—PTEN—uterine cancer	4.74e-06	5.01e-05	CbGpPWpGaD
Nifedipine—CALM3—Immune System—NRAS—uterine cancer	4.73e-06	5e-05	CbGpPWpGaD
Nifedipine—CALM3—Disease—EP300—uterine cancer	4.67e-06	4.94e-05	CbGpPWpGaD
Nifedipine—CALM2—Signaling Pathways—CCL2—uterine cancer	4.67e-06	4.93e-05	CbGpPWpGaD
Nifedipine—CALM1—Signaling Pathways—CCL2—uterine cancer	4.67e-06	4.93e-05	CbGpPWpGaD
Nifedipine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	4.6e-06	4.86e-05	CbGpPWpGaD
Nifedipine—CYP3A4—Metabolism—STK11—uterine cancer	4.58e-06	4.84e-05	CbGpPWpGaD
Nifedipine—CYP3A4—Metabolism—CYP19A1—uterine cancer	4.58e-06	4.84e-05	CbGpPWpGaD
Nifedipine—CALM2—Immune System—NRAS—uterine cancer	4.58e-06	4.84e-05	CbGpPWpGaD
Nifedipine—CALM1—Immune System—NRAS—uterine cancer	4.58e-06	4.84e-05	CbGpPWpGaD
Nifedipine—CALM2—Disease—EP300—uterine cancer	4.52e-06	4.78e-05	CbGpPWpGaD
Nifedipine—CALM1—Disease—EP300—uterine cancer	4.52e-06	4.78e-05	CbGpPWpGaD
Nifedipine—CYP1A2—Metabolism—MTHFR—uterine cancer	4.46e-06	4.72e-05	CbGpPWpGaD
Nifedipine—CALM3—Signaling by GPCR—KRAS—uterine cancer	4.46e-06	4.71e-05	CbGpPWpGaD
Nifedipine—CALM3—Disease—NRAS—uterine cancer	4.37e-06	4.62e-05	CbGpPWpGaD
Nifedipine—CALM2—Signaling by GPCR—KRAS—uterine cancer	4.31e-06	4.56e-05	CbGpPWpGaD
Nifedipine—CALM1—Signaling by GPCR—KRAS—uterine cancer	4.31e-06	4.56e-05	CbGpPWpGaD
Nifedipine—CALM1—Disease—NRAS—uterine cancer	4.23e-06	4.47e-05	CbGpPWpGaD
Nifedipine—CALM2—Disease—NRAS—uterine cancer	4.23e-06	4.47e-05	CbGpPWpGaD
Nifedipine—CYP2B6—Metabolism—PTEN—uterine cancer	4.21e-06	4.46e-05	CbGpPWpGaD
Nifedipine—CYP2E1—Metabolism—PTEN—uterine cancer	4.13e-06	4.36e-05	CbGpPWpGaD
Nifedipine—CYP3A5—Metabolism—PTEN—uterine cancer	4.12e-06	4.36e-05	CbGpPWpGaD
Nifedipine—CALM3—Metabolism—PTEN—uterine cancer	4.1e-06	4.34e-05	CbGpPWpGaD
Nifedipine—CALM3—Signaling by GPCR—PIK3CA—uterine cancer	4.1e-06	4.33e-05	CbGpPWpGaD
Nifedipine—CALM3—Immune System—KRAS—uterine cancer	4.07e-06	4.31e-05	CbGpPWpGaD
Nifedipine—CALM3—Signaling Pathways—ERBB2—uterine cancer	4.02e-06	4.25e-05	CbGpPWpGaD
Nifedipine—CYP3A7—Metabolism—PIK3CA—uterine cancer	4.02e-06	4.25e-05	CbGpPWpGaD
Nifedipine—CYP2B6—Metabolism—EP300—uterine cancer	4.02e-06	4.25e-05	CbGpPWpGaD
Nifedipine—CALM2—Metabolism—PTEN—uterine cancer	3.97e-06	4.2e-05	CbGpPWpGaD
Nifedipine—CALM1—Metabolism—PTEN—uterine cancer	3.97e-06	4.2e-05	CbGpPWpGaD
Nifedipine—CALM2—Signaling by GPCR—PIK3CA—uterine cancer	3.96e-06	4.19e-05	CbGpPWpGaD
Nifedipine—CALM1—Signaling by GPCR—PIK3CA—uterine cancer	3.96e-06	4.19e-05	CbGpPWpGaD
Nifedipine—CALM1—Immune System—KRAS—uterine cancer	3.94e-06	4.17e-05	CbGpPWpGaD
Nifedipine—CALM2—Immune System—KRAS—uterine cancer	3.94e-06	4.17e-05	CbGpPWpGaD
Nifedipine—CYP2E1—Metabolism—EP300—uterine cancer	3.94e-06	4.16e-05	CbGpPWpGaD
Nifedipine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	3.93e-06	4.16e-05	CbGpPWpGaD
Nifedipine—CYP3A5—Metabolism—EP300—uterine cancer	3.93e-06	4.15e-05	CbGpPWpGaD
Nifedipine—CALM3—Metabolism—EP300—uterine cancer	3.91e-06	4.14e-05	CbGpPWpGaD
Nifedipine—CYP1A1—Metabolism—PTEN—uterine cancer	3.89e-06	4.12e-05	CbGpPWpGaD
Nifedipine—CALM1—Signaling Pathways—ERBB2—uterine cancer	3.89e-06	4.11e-05	CbGpPWpGaD
Nifedipine—CALM2—Signaling Pathways—ERBB2—uterine cancer	3.89e-06	4.11e-05	CbGpPWpGaD
Nifedipine—CALM3—Signaling Pathways—CXCL8—uterine cancer	3.81e-06	4.03e-05	CbGpPWpGaD
Nifedipine—CALM3—Signaling by GPCR—HRAS—uterine cancer	3.79e-06	4.01e-05	CbGpPWpGaD
Nifedipine—CALM2—Metabolism—EP300—uterine cancer	3.78e-06	4e-05	CbGpPWpGaD
Nifedipine—CALM1—Metabolism—EP300—uterine cancer	3.78e-06	4e-05	CbGpPWpGaD
Nifedipine—CALM3—Disease—KRAS—uterine cancer	3.76e-06	3.98e-05	CbGpPWpGaD
Nifedipine—CALM3—Immune System—PIK3CA—uterine cancer	3.74e-06	3.96e-05	CbGpPWpGaD
Nifedipine—CALM3—Signaling Pathways—CDKN1B—uterine cancer	3.72e-06	3.94e-05	CbGpPWpGaD
Nifedipine—CYP1A1—Metabolism—EP300—uterine cancer	3.71e-06	3.92e-05	CbGpPWpGaD
Nifedipine—CALM2—Signaling Pathways—CXCL8—uterine cancer	3.69e-06	3.9e-05	CbGpPWpGaD
Nifedipine—CALM1—Signaling Pathways—CXCL8—uterine cancer	3.69e-06	3.9e-05	CbGpPWpGaD
Nifedipine—CYP2A6—Metabolism—PIK3CA—uterine cancer	3.69e-06	3.9e-05	CbGpPWpGaD
Nifedipine—CALM2—Signaling by GPCR—HRAS—uterine cancer	3.67e-06	3.88e-05	CbGpPWpGaD
Nifedipine—CALM1—Signaling by GPCR—HRAS—uterine cancer	3.67e-06	3.88e-05	CbGpPWpGaD
Nifedipine—CALM2—Disease—KRAS—uterine cancer	3.64e-06	3.85e-05	CbGpPWpGaD
Nifedipine—CALM1—Disease—KRAS—uterine cancer	3.64e-06	3.85e-05	CbGpPWpGaD
Nifedipine—CALM2—Immune System—PIK3CA—uterine cancer	3.62e-06	3.83e-05	CbGpPWpGaD
Nifedipine—CALM1—Immune System—PIK3CA—uterine cancer	3.62e-06	3.83e-05	CbGpPWpGaD
Nifedipine—CALM2—Signaling Pathways—CDKN1B—uterine cancer	3.6e-06	3.81e-05	CbGpPWpGaD
Nifedipine—CALM1—Signaling Pathways—CDKN1B—uterine cancer	3.6e-06	3.81e-05	CbGpPWpGaD
Nifedipine—CYP2C8—Metabolism—PTEN—uterine cancer	3.57e-06	3.77e-05	CbGpPWpGaD
Nifedipine—CALM3—Signaling Pathways—CTNNB1—uterine cancer	3.52e-06	3.72e-05	CbGpPWpGaD
Nifedipine—CALM3—Immune System—HRAS—uterine cancer	3.46e-06	3.66e-05	CbGpPWpGaD
Nifedipine—CALM3—Disease—PIK3CA—uterine cancer	3.46e-06	3.65e-05	CbGpPWpGaD
Nifedipine—CYP3A4—Metabolism—MTHFR—uterine cancer	3.44e-06	3.64e-05	CbGpPWpGaD
Nifedipine—CALM3—Signaling Pathways—PTEN—uterine cancer	3.43e-06	3.63e-05	CbGpPWpGaD
Nifedipine—CALM2—Signaling Pathways—CTNNB1—uterine cancer	3.4e-06	3.6e-05	CbGpPWpGaD
Nifedipine—CALM1—Signaling Pathways—CTNNB1—uterine cancer	3.4e-06	3.6e-05	CbGpPWpGaD
Nifedipine—CYP2C8—Metabolism—EP300—uterine cancer	3.4e-06	3.6e-05	CbGpPWpGaD
Nifedipine—CALM1—Immune System—HRAS—uterine cancer	3.35e-06	3.54e-05	CbGpPWpGaD
Nifedipine—CALM2—Immune System—HRAS—uterine cancer	3.35e-06	3.54e-05	CbGpPWpGaD
Nifedipine—CALM3—Signaling by GPCR—AKT1—uterine cancer	3.35e-06	3.54e-05	CbGpPWpGaD
Nifedipine—CALM2—Disease—PIK3CA—uterine cancer	3.34e-06	3.53e-05	CbGpPWpGaD
Nifedipine—CALM1—Disease—PIK3CA—uterine cancer	3.34e-06	3.53e-05	CbGpPWpGaD
Nifedipine—CALM2—Signaling Pathways—PTEN—uterine cancer	3.32e-06	3.51e-05	CbGpPWpGaD
Nifedipine—CALM1—Signaling Pathways—PTEN—uterine cancer	3.32e-06	3.51e-05	CbGpPWpGaD
Nifedipine—CYP3A7—Metabolism—AKT1—uterine cancer	3.28e-06	3.47e-05	CbGpPWpGaD
Nifedipine—CALM3—Signaling Pathways—EP300—uterine cancer	3.27e-06	3.46e-05	CbGpPWpGaD
Nifedipine—CALM1—Signaling by GPCR—AKT1—uterine cancer	3.24e-06	3.42e-05	CbGpPWpGaD
Nifedipine—CALM2—Signaling by GPCR—AKT1—uterine cancer	3.24e-06	3.42e-05	CbGpPWpGaD
Nifedipine—CALM3—Disease—HRAS—uterine cancer	3.2e-06	3.38e-05	CbGpPWpGaD
Nifedipine—CALM2—Signaling Pathways—EP300—uterine cancer	3.16e-06	3.35e-05	CbGpPWpGaD
Nifedipine—CALM1—Signaling Pathways—EP300—uterine cancer	3.16e-06	3.35e-05	CbGpPWpGaD
Nifedipine—ABCB1—Metabolism—PTEN—uterine cancer	3.11e-06	3.29e-05	CbGpPWpGaD
Nifedipine—CALM3—Signaling Pathways—VEGFA—uterine cancer	3.1e-06	3.28e-05	CbGpPWpGaD
Nifedipine—CALM2—Disease—HRAS—uterine cancer	3.09e-06	3.27e-05	CbGpPWpGaD
Nifedipine—CALM1—Disease—HRAS—uterine cancer	3.09e-06	3.27e-05	CbGpPWpGaD
Nifedipine—CALM3—Signaling Pathways—NRAS—uterine cancer	3.06e-06	3.24e-05	CbGpPWpGaD
Nifedipine—CALM3—Immune System—AKT1—uterine cancer	3.06e-06	3.23e-05	CbGpPWpGaD
Nifedipine—CYP2A6—Metabolism—AKT1—uterine cancer	3.01e-06	3.18e-05	CbGpPWpGaD
Nifedipine—CALM2—Signaling Pathways—VEGFA—uterine cancer	3e-06	3.17e-05	CbGpPWpGaD
Nifedipine—CALM1—Signaling Pathways—VEGFA—uterine cancer	3e-06	3.17e-05	CbGpPWpGaD
Nifedipine—CYP2B6—Metabolism—PIK3CA—uterine cancer	2.97e-06	3.14e-05	CbGpPWpGaD
Nifedipine—ABCB1—Metabolism—EP300—uterine cancer	2.96e-06	3.13e-05	CbGpPWpGaD
Nifedipine—CALM2—Signaling Pathways—NRAS—uterine cancer	2.96e-06	3.13e-05	CbGpPWpGaD
Nifedipine—CALM1—Signaling Pathways—NRAS—uterine cancer	2.96e-06	3.13e-05	CbGpPWpGaD
Nifedipine—CALM2—Immune System—AKT1—uterine cancer	2.96e-06	3.13e-05	CbGpPWpGaD
Nifedipine—CALM1—Immune System—AKT1—uterine cancer	2.96e-06	3.13e-05	CbGpPWpGaD
Nifedipine—CYP2D6—Metabolism—PTEN—uterine cancer	2.93e-06	3.1e-05	CbGpPWpGaD
Nifedipine—CYP2E1—Metabolism—PIK3CA—uterine cancer	2.91e-06	3.08e-05	CbGpPWpGaD
Nifedipine—CYP3A5—Metabolism—PIK3CA—uterine cancer	2.91e-06	3.07e-05	CbGpPWpGaD
Nifedipine—CYP2C9—Metabolism—PTEN—uterine cancer	2.9e-06	3.07e-05	CbGpPWpGaD
Nifedipine—CALM3—Metabolism—PIK3CA—uterine cancer	2.89e-06	3.06e-05	CbGpPWpGaD
Nifedipine—CALM3—Disease—AKT1—uterine cancer	2.82e-06	2.98e-05	CbGpPWpGaD
Nifedipine—CALM1—Metabolism—PIK3CA—uterine cancer	2.8e-06	2.96e-05	CbGpPWpGaD
Nifedipine—CALM2—Metabolism—PIK3CA—uterine cancer	2.8e-06	2.96e-05	CbGpPWpGaD
Nifedipine—CYP2D6—Metabolism—EP300—uterine cancer	2.79e-06	2.95e-05	CbGpPWpGaD
Nifedipine—CYP2C9—Metabolism—EP300—uterine cancer	2.77e-06	2.93e-05	CbGpPWpGaD
Nifedipine—CYP1A1—Metabolism—PIK3CA—uterine cancer	2.75e-06	2.9e-05	CbGpPWpGaD
Nifedipine—CALM1—Disease—AKT1—uterine cancer	2.73e-06	2.89e-05	CbGpPWpGaD
Nifedipine—CALM2—Disease—AKT1—uterine cancer	2.73e-06	2.89e-05	CbGpPWpGaD
Nifedipine—CALM3—Signaling Pathways—KRAS—uterine cancer	2.63e-06	2.78e-05	CbGpPWpGaD
Nifedipine—CALM1—Signaling Pathways—KRAS—uterine cancer	2.55e-06	2.69e-05	CbGpPWpGaD
Nifedipine—CALM2—Signaling Pathways—KRAS—uterine cancer	2.55e-06	2.69e-05	CbGpPWpGaD
Nifedipine—CYP2C8—Metabolism—PIK3CA—uterine cancer	2.52e-06	2.66e-05	CbGpPWpGaD
Nifedipine—CYP1A2—Metabolism—PTEN—uterine cancer	2.48e-06	2.62e-05	CbGpPWpGaD
Nifedipine—CYP2B6—Metabolism—AKT1—uterine cancer	2.43e-06	2.57e-05	CbGpPWpGaD
Nifedipine—CALM3—Signaling Pathways—PIK3CA—uterine cancer	2.42e-06	2.56e-05	CbGpPWpGaD
Nifedipine—CYP2E1—Metabolism—AKT1—uterine cancer	2.38e-06	2.52e-05	CbGpPWpGaD
Nifedipine—CYP3A5—Metabolism—AKT1—uterine cancer	2.37e-06	2.51e-05	CbGpPWpGaD
Nifedipine—CYP1A2—Metabolism—EP300—uterine cancer	2.37e-06	2.5e-05	CbGpPWpGaD
Nifedipine—CALM3—Metabolism—AKT1—uterine cancer	2.36e-06	2.5e-05	CbGpPWpGaD
Nifedipine—CALM3—Signaling Pathways—TP53—uterine cancer	2.34e-06	2.47e-05	CbGpPWpGaD
Nifedipine—CALM1—Signaling Pathways—PIK3CA—uterine cancer	2.34e-06	2.47e-05	CbGpPWpGaD
Nifedipine—CALM2—Signaling Pathways—PIK3CA—uterine cancer	2.34e-06	2.47e-05	CbGpPWpGaD
Nifedipine—CALM2—Metabolism—AKT1—uterine cancer	2.29e-06	2.42e-05	CbGpPWpGaD
Nifedipine—CALM1—Metabolism—AKT1—uterine cancer	2.29e-06	2.42e-05	CbGpPWpGaD
Nifedipine—CALM1—Signaling Pathways—TP53—uterine cancer	2.26e-06	2.39e-05	CbGpPWpGaD
Nifedipine—CALM2—Signaling Pathways—TP53—uterine cancer	2.26e-06	2.39e-05	CbGpPWpGaD
Nifedipine—CYP1A1—Metabolism—AKT1—uterine cancer	2.24e-06	2.37e-05	CbGpPWpGaD
Nifedipine—CALM3—Signaling Pathways—HRAS—uterine cancer	2.24e-06	2.37e-05	CbGpPWpGaD
Nifedipine—ABCB1—Metabolism—PIK3CA—uterine cancer	2.19e-06	2.32e-05	CbGpPWpGaD
Nifedipine—CALM2—Signaling Pathways—HRAS—uterine cancer	2.17e-06	2.29e-05	CbGpPWpGaD
Nifedipine—CALM1—Signaling Pathways—HRAS—uterine cancer	2.17e-06	2.29e-05	CbGpPWpGaD
Nifedipine—CYP2D6—Metabolism—PIK3CA—uterine cancer	2.07e-06	2.19e-05	CbGpPWpGaD
Nifedipine—CYP2C8—Metabolism—AKT1—uterine cancer	2.06e-06	2.17e-05	CbGpPWpGaD
Nifedipine—CYP2C9—Metabolism—PIK3CA—uterine cancer	2.05e-06	2.17e-05	CbGpPWpGaD
Nifedipine—CALM3—Signaling Pathways—AKT1—uterine cancer	1.98e-06	2.09e-05	CbGpPWpGaD
Nifedipine—CYP3A4—Metabolism—PTEN—uterine cancer	1.92e-06	2.03e-05	CbGpPWpGaD
Nifedipine—CALM1—Signaling Pathways—AKT1—uterine cancer	1.91e-06	2.02e-05	CbGpPWpGaD
Nifedipine—CALM2—Signaling Pathways—AKT1—uterine cancer	1.91e-06	2.02e-05	CbGpPWpGaD
Nifedipine—CYP3A4—Metabolism—EP300—uterine cancer	1.83e-06	1.93e-05	CbGpPWpGaD
Nifedipine—ABCB1—Metabolism—AKT1—uterine cancer	1.79e-06	1.89e-05	CbGpPWpGaD
Nifedipine—CYP1A2—Metabolism—PIK3CA—uterine cancer	1.75e-06	1.85e-05	CbGpPWpGaD
Nifedipine—CYP2D6—Metabolism—AKT1—uterine cancer	1.69e-06	1.78e-05	CbGpPWpGaD
Nifedipine—CYP2C9—Metabolism—AKT1—uterine cancer	1.67e-06	1.77e-05	CbGpPWpGaD
Nifedipine—CYP1A2—Metabolism—AKT1—uterine cancer	1.43e-06	1.51e-05	CbGpPWpGaD
Nifedipine—CYP3A4—Metabolism—PIK3CA—uterine cancer	1.35e-06	1.43e-05	CbGpPWpGaD
Nifedipine—CYP3A4—Metabolism—AKT1—uterine cancer	1.1e-06	1.17e-05	CbGpPWpGaD
